ATE325817T1 - Verfahren zur herstellung von immunoglobulin a in milch - Google Patents

Verfahren zur herstellung von immunoglobulin a in milch

Info

Publication number
ATE325817T1
ATE325817T1 AT98929914T AT98929914T ATE325817T1 AT E325817 T1 ATE325817 T1 AT E325817T1 AT 98929914 T AT98929914 T AT 98929914T AT 98929914 T AT98929914 T AT 98929914T AT E325817 T1 ATE325817 T1 AT E325817T1
Authority
AT
Austria
Prior art keywords
milk
producing
producing immunoglobulin
preparations
useful
Prior art date
Application number
AT98929914T
Other languages
German (de)
English (en)
Inventor
Alison Joy Hodgkinson
Steven Charles Hodgkinson
Original Assignee
Agres Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agres Ltd filed Critical Agres Ltd
Application granted granted Critical
Publication of ATE325817T1 publication Critical patent/ATE325817T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98929914T 1997-05-29 1998-05-29 Verfahren zur herstellung von immunoglobulin a in milch ATE325817T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ31495997 1997-05-29

Publications (1)

Publication Number Publication Date
ATE325817T1 true ATE325817T1 (de) 2006-06-15

Family

ID=19926267

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98929914T ATE325817T1 (de) 1997-05-29 1998-05-29 Verfahren zur herstellung von immunoglobulin a in milch

Country Status (9)

Country Link
US (3) US6616927B2 (enExample)
EP (1) EP0990001B1 (enExample)
JP (1) JP2002501526A (enExample)
AT (1) ATE325817T1 (enExample)
AU (1) AU738888B2 (enExample)
BR (1) BR9809186A (enExample)
CA (1) CA2291487A1 (enExample)
DE (1) DE69834490T2 (enExample)
WO (1) WO1998054226A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ285883B6 (cs) * 1998-01-19 1999-11-17 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě infekčních gastroenteritid telat
US20020009429A1 (en) * 1999-01-29 2002-01-24 Galagen, Inc. Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
DE60025945T2 (de) * 1999-11-01 2006-09-28 Mucovax Holding B.V. Herstellung von antikörpern in mammarsekreten von zuchttieren
US6974573B2 (en) 1999-11-01 2005-12-13 Mucovax Holdings, B.V. Antibody production in farm animals
US7074454B1 (en) 1999-11-01 2006-07-11 Mucovax Holding B.V. Production of mammary secretion antibodies in farm animals
WO2002072142A2 (en) * 2001-03-12 2002-09-19 Rijksuniversiteit Groningen Modulation of a balance between the gut mucosal immune system and the intestinal microflora
AU2002367161A1 (en) * 2001-12-24 2003-07-15 Fonterra Co-Operative Group Limited Immunoglobulin composition
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
FI116904B (fi) * 2003-10-21 2006-03-31 Suomen Rehu Oy Menetelmä maidon koostumuksen muuttamiseksi ja maidon käyttö
CA2543125A1 (en) * 2003-10-22 2005-05-12 Harry Leneau Colostrum compositions and methods
FR2861306B1 (fr) * 2003-10-28 2008-07-04 Vivafeed Utilisation du shiitake pour augmenter le taux d'immunoglobulines laitieres
AR046781A1 (es) 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
NZ530709A (en) * 2004-01-21 2006-07-28 Agres Ltd Improved IGA production method
US20080119508A1 (en) * 2004-12-30 2008-05-22 3M Innovative Properties Company Multi-Route Administration Of Immune Response Modifier Compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
TW200716664A (en) * 2005-05-10 2007-05-01 Murray Goulburn Coop Co Ltd Immunoglobulin fraction and process therefor
ES2642787T3 (es) * 2005-10-21 2017-11-20 Lfb Usa, Inc. Anticuerpos con actividad de citotoxicidad celular dependiente de anticuerpos mejorada, métodos para su producción y uso
BRPI0820744A2 (pt) * 2007-12-11 2014-12-23 Nestec Sa Prevenção e tratamento de otite média usando leite enriquecido com iga
EP2138187A1 (en) * 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and infection
WO2010050829A1 (en) * 2008-10-31 2010-05-06 Vialactia Biosciences (Nz) Limited Marker assisted selection of a mammalian subject for desired immunoglobulin phenotype
CA2818827C (en) 2010-11-23 2024-02-13 Pantheryx, Inc. Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
EP2956003A2 (en) 2013-02-13 2015-12-23 Laboratoire Français du Fractionnement et des Biotechnologies Proteins with modified glycosylation and methods of production thereof
KR20160002713A (ko) 2013-02-13 2016-01-08 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 고도로 갈락토실화된 항-tnf-알파 항체 및 이의 용도
WO2020176637A1 (en) 2019-02-26 2020-09-03 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
US4229342A (en) 1977-05-18 1980-10-21 Rhone-Poulenc Industries Process for extracting proteins from milk using silica and anion exchange resins
FR2520235A1 (fr) 1982-01-27 1983-07-29 Bel Fromageries Procede de separation d'immunoglobulines a partir de colostrum
US4971794A (en) * 1982-09-02 1990-11-20 Unilever Patent Holdings B.V. Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
DE3432718C1 (de) 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
US5066491A (en) 1985-04-15 1991-11-19 Protein Technology, Inc. Method of disease treatment utilizing an immunologically active whey fraction
FR2584727B1 (fr) 1985-07-11 1988-06-17 Roussel Uclaf Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
US5013824A (en) * 1985-11-19 1991-05-07 Schering Corporation Human interleukin-4 peptides and conjugates thereof
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
GB8729031D0 (en) 1987-12-11 1988-01-27 Express Foods Group Ltd Isolation of immunoglobulin rich fraction from whey
US5001230A (en) * 1988-02-18 1991-03-19 Schering Corporation T cell activation markers
US5258178A (en) 1990-07-30 1993-11-02 Abbott Laboratories Method and product for the treatment of gastric disease
IE76730B1 (en) * 1990-07-30 1997-11-05 Abbott Laboraties Method and product for the treatment of gastric disease
NZ239466A (en) 1990-08-17 1993-12-23 Us Agriculture Desalted colostrum: spray dried product from retentate of
US5418137A (en) * 1991-09-26 1995-05-23 Paravax, Inc. Flea membrane binding site proteins as screening tools
US5155213A (en) * 1991-10-28 1992-10-13 Eloy Padron Method for isolating IgAs in the feces
US5650173A (en) * 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
CA2242931A1 (en) 1996-01-31 1997-08-07 David Francis Elgar Production of an immunoglobulin enriched fraction from whey protein solutions

Also Published As

Publication number Publication date
US20030103989A1 (en) 2003-06-05
EP0990001B1 (en) 2006-05-10
EP0990001A4 (en) 2004-08-25
BR9809186A (pt) 2000-08-01
CA2291487A1 (en) 1998-12-03
DE69834490T2 (de) 2007-03-01
US6616927B2 (en) 2003-09-09
EP0990001A1 (en) 2000-04-05
AU738888B2 (en) 2001-09-27
JP2002501526A (ja) 2002-01-15
US20030074676A1 (en) 2003-04-17
DE69834490D1 (de) 2006-06-14
AU7942098A (en) 1998-12-30
WO1998054226A1 (en) 1998-12-03
US20020076410A1 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
DE69834490D1 (de) Verfahren zur herstellung von immunoglobulin a in milch
ATE238695T1 (de) Mayonnaiseähnliches produkt und verfahren zur herstellung desselben
DE69518308D1 (de) Produkt und verfahren zur herstellung von sukrosefreien milchschokoladen
ATE362707T1 (de) Verfahren zur herstellung von milchpulver und konzentrierten milchprodukten
FI971857L (fi) Menetelmä ei-diabetogeenisen maidon tai maitotuotteiden selektoimiseksi ja näin selektoitu maito tai maitotuote
ZA939295B (en) Milk product
ATE251387T1 (de) Verfahren zur herstellung von steriler entrahmter milch
AU3432595A (en) Method for producing calcium enriched fermented milk and fermented milk drink and the products
DE69329923D1 (de) Molkenprotein und molkenproteinhydrolysate, und verfahren zur herstellung
ATE300877T1 (de) Formulierung und verfahren zur herstellung von universaler fruchtbasis zur bereitung von nicht- sedimentierenden, weichen, sahnigen, dicken fruchtgetränken
ATE290003T1 (de) Verfahren zur herstellung von pyrazolo-(4,3- d)pyrimidin-7-ones und zwischenprodukte davon
ATE190050T1 (de) Verfahren zur herstellung von 2-acetyl-1-pyrrolin in verkapselter form, zwischenprodukte und endprodukt
DE69609893D1 (de) Verfahren zur Herstellung von mit Kalzium angereicherten Milchgetränken
DK0832564T3 (da) Calciumberiget mælk, mælkebaseret drik eller diætetisk produkt samt dets fremstillingsfremgangsmåde
ZA9610144B (en) Dairy product and process for making same.
ITRM920389A0 (it) Apparecchio per la preparazione e la distribuzione di prodotti di latte fermentato, particolarmente yogurt.
DE69003243D1 (de) Verfahren zur kontinuierlichen herstellung von "cottage cheese" aus ultrafiltrierter milch.
DE59704808D1 (de) Verfahren zur herstellung von kolostralmilchprodukten sowie deren verwendung
DE69001005D1 (de) Nahrungsmittelprodukt und verfahren zu seiner herstellung.
ATE228776T1 (de) Hydrokolloide enthaltende, expandierte nahrungs- und futtermittel und verfahren zur herstellung derselben
DE59208729D1 (de) Gekühlte, pasteurisierte, streichfähige Fleisch- oder Fischmousse sowie Verfahren zu ihrer Herstellung
ITVI910059A0 (it) Metodo per la pastorizzazione di prodotti alimentari e pastorizzatore atto a realizzare tale metodo
ATE140854T1 (de) Verwendung von stabilisierten molkeproteinpulvern zur herstellung von schmelzkäse und käsezubereitungen sowie verfahren zu ihrer herstellung
ATA224087A (de) Verfahren zur herstellung haltbarer, dehydrierter molkereiprodukte, naemlich butter und kaese
IT1275904B1 (it) Procedimento per la preparazione di prodotti alimentari contenenti concentrati di ortaggi e verdure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties